Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 69 citing articles:

Reactive oxygen species: a volatile driver of field cancerization and metastasis
Zehuan Liao, Damien Chua, Nguan Soon Tan
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 232
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
Funmilayo O. Adeshakin, Adeleye O. Adeshakin, Lukman O. Afolabi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 187
Cell Clustering Promotes a Metabolic Switch that Supports Metastatic Colonization
Christiaan F. Labuschagne, Eric C. Cheung, Julianna Blagih, et al.
Cell Metabolism (2019) Vol. 30, Iss. 4, pp. 720-734.e5
Open Access | Times Cited: 181
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Junmin Zhang, Dongzhu Duan, Zi‐Long Song, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 342-394
Closed Access | Times Cited: 144
Reactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression
Fabiola Lilí Sarmiento-Salinas, Andrea Perez-Gonzalez, Adilene Acosta-Casique, et al.
Life Sciences (2021) Vol. 284, pp. 119942-119942
Closed Access | Times Cited: 142
Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis
Sameer Ullah Khan, Kaneez Fatima, Fayaz Malik
Clinical & Experimental Metastasis (2022) Vol. 39, Iss. 5, pp. 715-726
Closed Access | Times Cited: 94
Oxidative Stress in Cancer Therapy: Friend or Enemy?
Maria Azmanova, Anaïs Pitto‐Barry
ChemBioChem (2022) Vol. 23, Iss. 10
Open Access | Times Cited: 87
Breast Cancer Subtypes Present a Differential Production of Reactive Oxygen Species (ROS) and Susceptibility to Antioxidant Treatment
Fabiola Lilí Sarmiento-Salinas, Alam Delgado-Magallón, José Benito Montes-Alvarado, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 133
Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial–mesenchymal transition
Caihua Wang, Liming Shao, Pan Chi, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 102
Implications of reactive oxygen species on cancer formation and its treatment
Manish A. Shah, Harry A. Rogoff
Seminars in Oncology (2021) Vol. 48, Iss. 3, pp. 238-245
Open Access | Times Cited: 68
Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling
Shangce Du, Zhi Yang, Xiaofeng Lu, et al.
Oncogene (2021) Vol. 40, Iss. 38, pp. 5764-5779
Closed Access | Times Cited: 64
Elevated NOX4 promotes tumorigenesis and acquired EGFR-TKIs resistance via enhancing IL-8/PD-L1 signaling in NSCLC
Wenjing Liu, Lin Wang, Feng-Mei Zhou, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100987-100987
Open Access | Times Cited: 30
Targeting anoikis resistance as a strategy for cancer therapy
Yumin Wang, Sihang Cheng, Joshua S. Fleishman, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101099-101099
Closed Access | Times Cited: 11
Inhibiting the Activity of NADPH Oxidase in Cancer
Mariam M. Konaté, Smitha Antony, James H. Doroshow
Antioxidants and Redox Signaling (2020) Vol. 33, Iss. 6, pp. 435-454
Open Access | Times Cited: 56
Cancer and Autoimmune Diseases: A Tale of Two Immunological Opposites?
Zeev Elkoshi
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
NADPH Oxidase 4 (NOX4) in Cancer: Linking Redox Signals to Oncogenic Metabolic Adaptation
Ildikó Szántó
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2702-2702
Open Access | Times Cited: 34
Survival mechanisms of circulating tumor cells and their implications for cancer treatment
Shuang Zhou, Huanji Xu, Yichun Duan, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 6
An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
Guizhen Zhang, Zhu Weiwei, Yun Wang, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 14
Metabolic reprogramming and signaling adaptations in anoikis resistance: mechanisms and therapeutic targets
Chao He, Jie He
Molecular and Cellular Biochemistry (2025)
Closed Access
Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
Ziyi Zhou, Lanlan Yang, Yuan Fang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis
Qian Chen, Lang Hu, Kai-Hua Chen
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 37
Reductive Stress, Bioactive Compounds, Redox-Active Metals, and Dormant Tumor Cell Biology to Develop Redox-Based Tools for the Treatment of Cancer
José L. Quiles, Cristina Sánchez‐González, Laura Vera‐Ramirez, et al.
Antioxidants and Redox Signaling (2020) Vol. 33, Iss. 12, pp. 860-881
Closed Access | Times Cited: 34
Systematic identification of a nuclear receptor-enriched predictive signature for erastin-induced ferroptosis
Ok-Seon Kwon, Eun-Ji Kwon, Hyeon-Joon Kong, et al.
Redox Biology (2020) Vol. 37, pp. 101719-101719
Open Access | Times Cited: 33
NADPH Oxidase 4: A Potential Therapeutic Target of Malignancy
Shulei Gong, Shiyang Wang, Mingrui Shao
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20
Empagliflozin drives ferroptosis in anoikis-resistant cells by activating miR-128-3p dependent pathway and inhibiting CD98hc in breast cancer.
Lakshmi Vineela Nalla, Amit Khairnar
Free Radical Biology and Medicine (2024) Vol. 220, pp. 288-300
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top